1. Home
  2. PLNT vs BLCO Comparison

PLNT vs BLCO Comparison

Compare PLNT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLNT
  • BLCO
  • Stock Information
  • Founded
  • PLNT 1992
  • BLCO 1853
  • Country
  • PLNT United States
  • BLCO Canada
  • Employees
  • PLNT N/A
  • BLCO N/A
  • Industry
  • PLNT Hotels/Resorts
  • BLCO Ophthalmic Goods
  • Sector
  • PLNT Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • PLNT Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • PLNT 6.9B
  • BLCO 7.0B
  • IPO Year
  • PLNT 2015
  • BLCO 2022
  • Fundamental
  • Price
  • PLNT $100.02
  • BLCO $19.80
  • Analyst Decision
  • PLNT Buy
  • BLCO Buy
  • Analyst Count
  • PLNT 17
  • BLCO 11
  • Target Price
  • PLNT $89.47
  • BLCO $21.30
  • AVG Volume (30 Days)
  • PLNT 1.4M
  • BLCO 429.8K
  • Earning Date
  • PLNT 11-07-2024
  • BLCO 10-30-2024
  • Dividend Yield
  • PLNT N/A
  • BLCO N/A
  • EPS Growth
  • PLNT 15.44
  • BLCO N/A
  • EPS
  • PLNT 1.86
  • BLCO N/A
  • Revenue
  • PLNT $1,049,214,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • PLNT $24.44
  • BLCO $17.44
  • Revenue Next Year
  • PLNT $10.35
  • BLCO $6.18
  • P/E Ratio
  • PLNT $53.77
  • BLCO N/A
  • Revenue Growth
  • PLNT 4.90
  • BLCO 18.01
  • 52 Week Low
  • PLNT $54.35
  • BLCO $13.16
  • 52 Week High
  • PLNT $100.63
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • PLNT 78.57
  • BLCO 50.37
  • Support Level
  • PLNT $94.44
  • BLCO $19.31
  • Resistance Level
  • PLNT $97.34
  • BLCO $20.23
  • Average True Range (ATR)
  • PLNT 2.94
  • BLCO 0.51
  • MACD
  • PLNT 1.00
  • BLCO -0.11
  • Stochastic Oscillator
  • PLNT 97.33
  • BLCO 35.04

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: